Technology for the human nervous system.
Leptir is building a user-centred neurotechnology ecosystem designed to help people understand sleep, headache, attention, cognition and sensory-motor wellbeing.
Healthcare technology was built around the clinic.
Leptir is building around the person.
Clinical care matters. But a person's neurological experience does not pause between appointments — it runs through every night of sleep, every working afternoon and every headache that arrives without warning. Leptir is building technology around that everyday experience.
The clinical path
- Clinic
- Consultation
- Snapshot
- Decision
The everyday path Leptir is building
- Everyday life
- Continuous understanding
- Personal patterns
- Personalised intelligence
- Empowerment
The nervous system doesn't operate in silos.
Sleep affects headache. Headache affects attention. Attention affects how the day is judged. Leptir is designing five connected areas rather than five separate apps.
Four principles. One ecosystem.
EP3 is the standard every Leptir product is measured against, from the first release onwards.
Empowerment
Understand yourself.
Technology should help people understand their own patterns, symptoms, behaviour and wellbeing rather than hand that understanding to somebody else.
Performance
Function better.
Sleep, cognition, attention and neurological wellbeing shape how people perform every day, at work and everywhere else.
Personalised
Built around the individual.
People experience symptoms, environments, behaviours and neurological states differently. Technology should adapt to the individual, not the average.
Privacy
Your data belongs to you.
Privacy is treated as part of the architecture and the product philosophy, not as a legal statement added at the end.
Days without a headache
12 / 14
Illustrative interface. Not real user data.
Meet Akeso.
Headache intelligence built around you.
Akeso is Leptir's first product, combining symptom tracking, personalisation and predictive intelligence to help people understand their headache and migraine patterns. It is in development.
01
Track
Symptoms and the context around them, in seconds.
02
Understand
Patterns that only appear across weeks, not days.
03
Predict
Intelligence designed to anticipate difficult days.
04
Personalise
A model that adapts to one person, not a population.
Intelligence that learns the individual.
Leptir's technical direction is to keep as much understanding as close to the person as is practical, and to treat longitudinal personal data as the asset that makes personalisation possible.
Data
Symptoms, sleep, context, environment and behaviour, recorded with as little effort from the person as possible.
Intelligence
Longitudinal analysis designed to find the patterns that belong to one individual rather than to an average.
Insight
Something the person can act on today, expressed in plain language rather than in clinical scores.
Your nervous system is not a commodity.
Leptir is being designed around privacy-first principles, with a focus on minimising unnecessary data movement and exploring local and on-device intelligence wherever appropriate.
Neurological information is among the most personal information a person holds. Leptir's position is that it should not be traded, and that the architecture should make unnecessary data movement difficult rather than merely discouraged. Read the privacy policy
One product. A larger ecosystem.
Akeso comes first because headache is where personal pattern-finding is most immediately useful. The rest of the ecosystem follows.
Now
- Akeso — headache intelligence
- EP3 product standard
Next
- Sleep
- Attention
- Sensory and motor
- Cognition
Future
- Connected neurotechnology
- Apps, wearables and personalised intelligence
Built by medicine. Designed around people.
Leptir Ltd was established on 13 May 2026 in the United Kingdom.
Founder
Dr Sandeep Kumar, MD
Founder of Leptir Ltd, working on technology that sits with the person rather than with the clinic.
Advisor
Dr Arjuna Nagendran
Advisor to Leptir Ltd.
Building a new category of neurotechnology.
Leptir is an early-stage company. If you are an investor, a journalist or a potential partner, the fastest route is a direct conversation.